David R. Byrd, MD
Life throws us all curveballs; it’s not a question of whether you will get them, it’s when. Fueled by a love of anatomy, I learned early on that I wanted to support people whose lives had been knocked off course by cancer. This desire only grew stronger when I traveled to India and Pakistan after my general surgery residency to do volunteer medical work. My experiences as a surgical oncologist have taught me that it’s the quality of our time in this world that counts, and the time I have spent treating patients with cancer — learning about their lives and helping them overcome health obstacles — has been tremendously rewarding.
Regardless of your diagnosis, I want to make sure you walk out of the clinic feeling better than when you walked in. I am always forthright, but I never take away hope. One of the things I value about SCCA is how patient-centered it is, and my approach mirrors the belief that what you care about and what you need always takes center stage. I see my role as bringing in the evidence — what we know about treatment and prognosis — and mapping that information onto your goals, so we can form a care plan that reflects your unique preferences.
As the director of surgery at SCCA, I have a diverse interest in the management of several different solid tumors. Breast cancer is one of my areas of expertise. I was the first surgeon to bring the sentinel lymph node biopsy to the Pacific Northwest; this technique improved the management of breast cancer, and other cancers, by more accurately determining whether the disease has spread to the lymphatic system, eliminating the need for more invasive surgery. I have also published articles on topics including node-positive breast cancer, tumor detection and complications of breast cancer treatment such as lymphedema.
I provide comprehensive surgical care for melanoma and other skin cancers through SCCA’s Skin Oncology Clinic. Outside of patient care, I have led the development of staging systems for malignant melanoma, as well as other cancers, and I actively conduct research to improve the standard of care. For example, I co-led a study demonstrating that removing key sentinel lymph nodes from most patients with early-stage melanoma led to the same long-term survival rates as fully removing additional lymph nodes. Sentinel lymph node removal is associated with improved health outcomes and fewer complications.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
SCCA’s Sara H. Javid, MD, Mika N. Sinanan, MD, PhD, Kristine E. Calhoun, MD, Brant K. Oelschlager, MD, FACS, and David R. Byrd, MD, were named to Seattle Magazine’s list of Top Doctors in Seattle for 2021, recognizing their excellence in surgery.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.